New Imaging Technology Provides Fly-Through Views of the Inner Brain Processes
|
By LabMedica International staff writers Posted on 02 Jul 2014 |

Image: A three-dimensional rendering of clarified brain imaged from below (Photo courtesy of Deisseroth lab).
Scientists have improved on an original technique for looking into the intact brain, making it more effective and safer. This new application could help scientists better determine the inner connections of how thoughts, memories, or diseases occur.
In 2013, Karl Deisseroth, a Stanford University (Stanford, CA, USA), a professor of bioengineering and of psychiatry and behavioral sciences, reported on a new way of peering into a brain—removed from the body—that provided remarkable fly-through views of its inner connections. Since then, laboratories worldwide have begun using the technique, called CLARITY (Clear, Lipid-exchanged, Acrylamide-hybridized Rigid, Imaging/immunostaining-compatible, Tissue hYdrogel), with some success, to better understand the brain’s wiring.
However, Prof. Deisseroth reported that with two technologic corrections, CLARITY could be even more widely accepted. The first problem was that laboratories were not set up to effectively carry out the CLARITY process. Second, the most typically available microscopy technology not designed to image the whole transparent brain. “There have been a number of remarkable results described using CLARITY,” Dr. Deisseroth said, “but we needed to address these two distinct challenges to make the technology easier to use.”
In a Nature Protocols journal article published June 19, 2014, Dr. Deisseroth presented solutions to both of those bottlenecks. “These transform CLARITY, making the overall process much easier and the data collection much faster,” he said. He and his colleagues anticipate that even more scientists will now be able to take advantage of the technique to better understand the brain at a fundamental level, and also to investigate the origins of brain diseases.
This study may be the first to be published with support of the US White House BRAIN Initiative, announced in 2013 with the goal of mapping the brain’s trillions of nerve connections and determining how signals zip through those interconnected cells to control our thoughts, memories, movement and everything else that makes humans the way they are. “This work shares the spirit of the BRAIN Initiative goal of building new technologies to understand the brain—including the human brain,” said Prof. Deisseroth, who is also a Stanford Bio-X affiliated faculty member.
When one looks at the brain, what one sees is the fatty outer covering of the nerve cells within, which blocks microscopes from taking images of the subtle connections between deep brain cells. The plan behind CLARITY was to eliminate that fatty covering while keeping the brain intact, complete with all its intricate inner wiring. The way, the investigators eliminated the fat was to build a gel within the intact brain that held all the structures and proteins in place. They then used an electric field to pull out the fat layer that had been dissolved in an electrically charged detergent, leaving behind all the brain’s structures embedded in the firm water-based gel, or hydrogel. This is called electrophoretic CLARITY.
The electric field feature was troublesome for some labs. “About half the people who tried it got it working right away,” Prof. Deisseroth said, “but others had problems with the voltage damaging tissue.” He reported that this kind of challenge is normal when introducing new technologies. When he first introduced optogenetics, which allows scientists to control individual nerves using light, a similar proportion of labs were not initially set up to easily implement the new technology, and ran into challenges.
To help expand the use of CLARITY, the investigators devised an alternate way of pulling out the fat from the hydrogel-embedded brain—a technique they call passive CLARITY. It takes a little longer, but still removes all the fat, is much easier and does not pose a risk to the tissue. “Electrophoretic CLARITY is important for cases where speed is critical, and for some tissues,” said Prof. Deisseroth, who is also a professor. “But passive CLARITY is a crucial advance for the community, especially for neuroscience.” Passive CLARITY requires nothing more than some chemicals, a warm bath and time.
Many groups have begun to apply CLARITY to probe brains donated from people who had diseases like epilepsy or autism, which might have left clues in the brain to help scientists understand and ultimately treat the disease. However, scientists, including Prof. Deisseroth, had been wary of trying electrophoretic CLARTY on these valuable clinical samples with even a very low risk of damage. “It’s a rare and precious donated sample, you don’t want to have a chance of damage or error,” Prof. Deisseroth said. “Now the risk issue is addressed, and on top of that you can get the data very rapidly.”
The second advance had to do this rapidity of data collection. In studying any cells, scientists often make use of probes that will go into the cell or tissue, latch onto a particular molecule, then glow green, blue, yellow, or other colors in response to particular wavelengths of light. This is what generates the colorful cellular images that are so common in biology research. Using CLARITY, these colorful structures become visible throughout the complete brain, because no fat remains to block the light.
The difficulty is that those probes stop working, or get bleached, after they have been exposed to too much light. That is acceptable if a scientist is just taking a picture of a small cellular structure, which takes little time. However, to get a high-resolution image of an entire brain, the whole tissue is immersed in light throughout the time it takes to image it piece by piece. This approach bleaches out the probes before the entire brain can be imaged at high resolution.
The second development of the new study tackles this problem, making it easier to image the entire brain without bleaching the probes. “We can now scan an entire plane at one time instead of a point,” Prof. Deisseroth said. “That buys you a couple orders of magnitude of time, and also efficiently delivers light only to where the imaging is happening.”
The technique is called light sheet microscopy and has been around for some time, but earlier did not have high enough resolution to see the fine details of cellular structures. “We advanced traditional light sheet microscopy for CLARITY, and can now see fine wiring structures deep within an intact adult brain,” Prof. Deisseroth commented.
Prof. Deisseroth’s lab constructed their own microscope, but the procedures are described in the paper, and the key components are commercially available. Furthermore, the lab provides free training courses in CLARITY, modeled after his optogenetics courses, to help disseminate the techniques.
Related Links:
Stanford University
In 2013, Karl Deisseroth, a Stanford University (Stanford, CA, USA), a professor of bioengineering and of psychiatry and behavioral sciences, reported on a new way of peering into a brain—removed from the body—that provided remarkable fly-through views of its inner connections. Since then, laboratories worldwide have begun using the technique, called CLARITY (Clear, Lipid-exchanged, Acrylamide-hybridized Rigid, Imaging/immunostaining-compatible, Tissue hYdrogel), with some success, to better understand the brain’s wiring.
However, Prof. Deisseroth reported that with two technologic corrections, CLARITY could be even more widely accepted. The first problem was that laboratories were not set up to effectively carry out the CLARITY process. Second, the most typically available microscopy technology not designed to image the whole transparent brain. “There have been a number of remarkable results described using CLARITY,” Dr. Deisseroth said, “but we needed to address these two distinct challenges to make the technology easier to use.”
In a Nature Protocols journal article published June 19, 2014, Dr. Deisseroth presented solutions to both of those bottlenecks. “These transform CLARITY, making the overall process much easier and the data collection much faster,” he said. He and his colleagues anticipate that even more scientists will now be able to take advantage of the technique to better understand the brain at a fundamental level, and also to investigate the origins of brain diseases.
This study may be the first to be published with support of the US White House BRAIN Initiative, announced in 2013 with the goal of mapping the brain’s trillions of nerve connections and determining how signals zip through those interconnected cells to control our thoughts, memories, movement and everything else that makes humans the way they are. “This work shares the spirit of the BRAIN Initiative goal of building new technologies to understand the brain—including the human brain,” said Prof. Deisseroth, who is also a Stanford Bio-X affiliated faculty member.
When one looks at the brain, what one sees is the fatty outer covering of the nerve cells within, which blocks microscopes from taking images of the subtle connections between deep brain cells. The plan behind CLARITY was to eliminate that fatty covering while keeping the brain intact, complete with all its intricate inner wiring. The way, the investigators eliminated the fat was to build a gel within the intact brain that held all the structures and proteins in place. They then used an electric field to pull out the fat layer that had been dissolved in an electrically charged detergent, leaving behind all the brain’s structures embedded in the firm water-based gel, or hydrogel. This is called electrophoretic CLARITY.
The electric field feature was troublesome for some labs. “About half the people who tried it got it working right away,” Prof. Deisseroth said, “but others had problems with the voltage damaging tissue.” He reported that this kind of challenge is normal when introducing new technologies. When he first introduced optogenetics, which allows scientists to control individual nerves using light, a similar proportion of labs were not initially set up to easily implement the new technology, and ran into challenges.
To help expand the use of CLARITY, the investigators devised an alternate way of pulling out the fat from the hydrogel-embedded brain—a technique they call passive CLARITY. It takes a little longer, but still removes all the fat, is much easier and does not pose a risk to the tissue. “Electrophoretic CLARITY is important for cases where speed is critical, and for some tissues,” said Prof. Deisseroth, who is also a professor. “But passive CLARITY is a crucial advance for the community, especially for neuroscience.” Passive CLARITY requires nothing more than some chemicals, a warm bath and time.
Many groups have begun to apply CLARITY to probe brains donated from people who had diseases like epilepsy or autism, which might have left clues in the brain to help scientists understand and ultimately treat the disease. However, scientists, including Prof. Deisseroth, had been wary of trying electrophoretic CLARTY on these valuable clinical samples with even a very low risk of damage. “It’s a rare and precious donated sample, you don’t want to have a chance of damage or error,” Prof. Deisseroth said. “Now the risk issue is addressed, and on top of that you can get the data very rapidly.”
The second advance had to do this rapidity of data collection. In studying any cells, scientists often make use of probes that will go into the cell or tissue, latch onto a particular molecule, then glow green, blue, yellow, or other colors in response to particular wavelengths of light. This is what generates the colorful cellular images that are so common in biology research. Using CLARITY, these colorful structures become visible throughout the complete brain, because no fat remains to block the light.
The difficulty is that those probes stop working, or get bleached, after they have been exposed to too much light. That is acceptable if a scientist is just taking a picture of a small cellular structure, which takes little time. However, to get a high-resolution image of an entire brain, the whole tissue is immersed in light throughout the time it takes to image it piece by piece. This approach bleaches out the probes before the entire brain can be imaged at high resolution.
The second development of the new study tackles this problem, making it easier to image the entire brain without bleaching the probes. “We can now scan an entire plane at one time instead of a point,” Prof. Deisseroth said. “That buys you a couple orders of magnitude of time, and also efficiently delivers light only to where the imaging is happening.”
The technique is called light sheet microscopy and has been around for some time, but earlier did not have high enough resolution to see the fine details of cellular structures. “We advanced traditional light sheet microscopy for CLARITY, and can now see fine wiring structures deep within an intact adult brain,” Prof. Deisseroth commented.
Prof. Deisseroth’s lab constructed their own microscope, but the procedures are described in the paper, and the key components are commercially available. Furthermore, the lab provides free training courses in CLARITY, modeled after his optogenetics courses, to help disseminate the techniques.
Related Links:
Stanford University
Latest BioResearch News
- Genome Analysis Predicts Likelihood of Neurodisability in Oxygen-Deprived Newborns
- Gene Panel Predicts Disease Progession for Patients with B-cell Lymphoma
- New Method Simplifies Preparation of Tumor Genomic DNA Libraries
- New Tool Developed for Diagnosis of Chronic HBV Infection
- Panel of Genetic Loci Accurately Predicts Risk of Developing Gout
- Disrupted TGFB Signaling Linked to Increased Cancer-Related Bacteria
- Gene Fusion Protein Proposed as Prostate Cancer Biomarker
- NIV Test to Diagnose and Monitor Vascular Complications in Diabetes
- Semen Exosome MicroRNA Proves Biomarker for Prostate Cancer
- Genetic Loci Link Plasma Lipid Levels to CVD Risk
- Newly Identified Gene Network Aids in Early Diagnosis of Autism Spectrum Disorder
- Link Confirmed between Living in Poverty and Developing Diseases
- Genomic Study Identifies Kidney Disease Loci in Type I Diabetes Patients
- Liquid Biopsy More Effective for Analyzing Tumor Drug Resistance Mutations
- New Liquid Biopsy Assay Reveals Host-Pathogen Interactions
- Method Developed for Enriching Trophoblast Population in Samples
Channels
Clinical Chemistry
view channel
New PSA-Based Prognostic Model Improves Prostate Cancer Risk Assessment
Prostate cancer is the second-leading cause of cancer death among American men, and about one in eight will be diagnosed in their lifetime. Screening relies on blood levels of prostate-specific antigen... Read more
Extracellular Vesicles Linked to Heart Failure Risk in CKD Patients
Chronic kidney disease (CKD) affects more than 1 in 7 Americans and is strongly associated with cardiovascular complications, which account for more than half of deaths among people with CKD.... Read moreMolecular Diagnostics
view channel
Diagnostic Device Predicts Treatment Response for Brain Tumors Via Blood Test
Glioblastoma is one of the deadliest forms of brain cancer, largely because doctors have no reliable way to determine whether treatments are working in real time. Assessing therapeutic response currently... Read more
Blood Test Detects Early-Stage Cancers by Measuring Epigenetic Instability
Early-stage cancers are notoriously difficult to detect because molecular changes are subtle and often missed by existing screening tools. Many liquid biopsies rely on measuring absolute DNA methylation... Read more
“Lab-On-A-Disc” Device Paves Way for More Automated Liquid Biopsies
Extracellular vesicles (EVs) are tiny particles released by cells into the bloodstream that carry molecular information about a cell’s condition, including whether it is cancerous. However, EVs are highly... Read more
Blood Test Identifies Inflammatory Breast Cancer Patients at Increased Risk of Brain Metastasis
Brain metastasis is a frequent and devastating complication in patients with inflammatory breast cancer, an aggressive subtype with limited treatment options. Despite its high incidence, the biological... Read moreHematology
view channel
New Guidelines Aim to Improve AL Amyloidosis Diagnosis
Light chain (AL) amyloidosis is a rare, life-threatening bone marrow disorder in which abnormal amyloid proteins accumulate in organs. Approximately 3,260 people in the United States are diagnosed... Read more
Fast and Easy Test Could Revolutionize Blood Transfusions
Blood transfusions are a cornerstone of modern medicine, yet red blood cells can deteriorate quietly while sitting in cold storage for weeks. Although blood units have a fixed expiration date, cells from... Read more
Automated Hemostasis System Helps Labs of All Sizes Optimize Workflow
High-volume hemostasis sections must sustain rapid turnaround while managing reruns and reflex testing. Manual tube handling and preanalytical checks can strain staff time and increase opportunities for error.... Read more
High-Sensitivity Blood Test Improves Assessment of Clotting Risk in Heart Disease Patients
Blood clotting is essential for preventing bleeding, but even small imbalances can lead to serious conditions such as thrombosis or dangerous hemorrhage. In cardiovascular disease, clinicians often struggle... Read moreImmunology
view channelBlood Test Identifies Lung Cancer Patients Who Can Benefit from Immunotherapy Drug
Small cell lung cancer (SCLC) is an aggressive disease with limited treatment options, and even newly approved immunotherapies do not benefit all patients. While immunotherapy can extend survival for some,... Read more
Whole-Genome Sequencing Approach Identifies Cancer Patients Benefitting From PARP-Inhibitor Treatment
Targeted cancer therapies such as PARP inhibitors can be highly effective, but only for patients whose tumors carry specific DNA repair defects. Identifying these patients accurately remains challenging,... Read more
Ultrasensitive Liquid Biopsy Demonstrates Efficacy in Predicting Immunotherapy Response
Immunotherapy has transformed cancer treatment, but only a small proportion of patients experience lasting benefit, with response rates often remaining between 10% and 20%. Clinicians currently lack reliable... Read moreMicrobiology
view channel
Comprehensive Review Identifies Gut Microbiome Signatures Associated With Alzheimer’s Disease
Alzheimer’s disease affects approximately 6.7 million people in the United States and nearly 50 million worldwide, yet early cognitive decline remains difficult to characterize. Increasing evidence suggests... Read moreAI-Powered Platform Enables Rapid Detection of Drug-Resistant C. Auris Pathogens
Infections caused by the pathogenic yeast Candida auris pose a significant threat to hospitalized patients, particularly those with weakened immune systems or those who have invasive medical devices.... Read morePathology
view channel
Engineered Yeast Cells Enable Rapid Testing of Cancer Immunotherapy
Developing new cancer immunotherapies is a slow, costly, and high-risk process, particularly for CAR T cell treatments that must precisely recognize cancer-specific antigens. Small differences in tumor... Read more
First-Of-Its-Kind Test Identifies Autism Risk at Birth
Autism spectrum disorder is treatable, and extensive research shows that early intervention can significantly improve cognitive, social, and behavioral outcomes. Yet in the United States, the average age... Read moreTechnology
view channel
Robotic Technology Unveiled for Automated Diagnostic Blood Draws
Routine diagnostic blood collection is a high‑volume task that can strain staffing and introduce human‑dependent variability, with downstream implications for sample quality and patient experience.... Read more
ADLM Launches First-of-Its-Kind Data Science Program for Laboratory Medicine Professionals
Clinical laboratories generate billions of test results each year, creating a treasure trove of data with the potential to support more personalized testing, improve operational efficiency, and enhance patient care.... Read moreAptamer Biosensor Technology to Transform Virus Detection
Rapid and reliable virus detection is essential for controlling outbreaks, from seasonal influenza to global pandemics such as COVID-19. Conventional diagnostic methods, including cell culture, antigen... Read more
AI Models Could Predict Pre-Eclampsia and Anemia Earlier Using Routine Blood Tests
Pre-eclampsia and anemia are major contributors to maternal and child mortality worldwide, together accounting for more than half a million deaths each year and leaving millions with long-term health complications.... Read moreIndustry
view channelNew Collaboration Brings Automated Mass Spectrometry to Routine Laboratory Testing
Mass spectrometry is a powerful analytical technique that identifies and quantifies molecules based on their mass and electrical charge. Its high selectivity, sensitivity, and accuracy make it indispensable... Read more
AI-Powered Cervical Cancer Test Set for Major Rollout in Latin America
Noul Co., a Korean company specializing in AI-based blood and cancer diagnostics, announced it will supply its intelligence (AI)-based miLab CER cervical cancer diagnostic solution to Mexico under a multi‑year... Read more
Diasorin and Fisher Scientific Enter into US Distribution Agreement for Molecular POC Platform
Diasorin (Saluggia, Italy) has entered into an exclusive distribution agreement with Fisher Scientific, part of Thermo Fisher Scientific (Waltham, MA, USA), for the LIAISON NES molecular point-of-care... Read more






 Analyzer.jpg)
